People with HIV are at increased risk of being reinfected with the virus that causes COVID-19, according to new federal data. Researchers from the Centers for Disease Control and Prevention and the ...
The Centers for Disease Control and Prevention (CDC) has come out with a strong recommendation for the use of Gilead Sciences’ twice-yearly HIV pre-exposure prophylaxis (PrEP) med Yeztugo, ...
Ed Silverman, a senior writer and Pharmalot columnist at STAT, has been covering the pharmaceutical industry for nearly three decades. He is also the author of the morning Pharmalittle newsletter and ...
The CDC made a strong recommendation based on a high certainty of evidence to use the long-acting injectable lenacapavir (Yeztugo) for HIV pre-exposure prophylaxis (PrEP), but will that ensure the ...
Hosted on MSN
CDC's HIV Prevention Division Readies for Its Demise
The Trump administration's battering of global HIV programs has garnered much attention, but infectious disease experts are concerned about HIV prevention at home, too. The CDC's Division of HIV ...
”The alarming numbers show us, and epidemiological data show us that over the years, we really need to add resources…. We certainly believe a national investment in prevention would allow us to bring ...
Funding for an Atlanta-based program that has provided nearly 1 million free HIV home testing kits nationwide has been restored, allowing it to continue for another year. Together Take Me Home, based ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback